Recombinant Bacillus subtilis expressing highly pathogenic avian influenza h5n1 hemagglutinin ha protein
A Bacillus subtilis, highly pathogenic technology, applied in the field of biotechnology genetic engineering, can solve the problems of pathogenicity, attenuated bacteria virulence, and somatic cell carcinogenesis.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0051] 1 Construction of expression plasmid pHT43-HA
[0052] The methods used in the following examples are conventional methods unless otherwise specified. The specific materials and reagents involved are as follows:
[0053] Bacillus subtilis WB800N strain was donated by Gao Xuewen, School of Plant Protection, Nanjing Agricultural University;
[0054] The pMD19-HA plasmid was donated by Wang Zhisheng, Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences;
[0055] The highly pathogenic avian influenza H5N1 strain was donated by Fan Gencheng of Qingdao Tianbang Biological Co., Ltd.;
[0056] E.coli JM109 strain and plasmid pMD19-T were purchased from Takara; plasmid pHT43 was purchased from LifeTechnologies;
[0057] Reagents: Q5 high-fidelity enzyme was purchased from NEB Company; agarose gel recovery kit, restriction endonuclease, T4 ligase, Trizol, RNA reverse transcription kit, fluorescence quantitative kit, etc. were purchased from Takara Company...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com